Key result
Lipopeptide vaccination with FMDV-specific B-cell epitopes protected 4 out of 7 cattle against challenge infection with homologous foot-and-mouth disease virus.
Lipopeptide vaccination with FMDV-specific B-cell epitopes provided partial protection in cattle, which correlated with the onset of an antigen-specific T-cell reaction.
Answers are grounded in this paper and cite their sources.
Partial protection in cattle is hypothesis-generating; larger trials needed before veterinary translation.
To evaluate the potential of chemically synthesized lipopeptides for vaccination against foot-and-mouth disease (FMD), seven lipopeptides containing the immunostimulating principle of bacterial lipoproteins and linear B-cell epitopes of FMDV strain O(1)Kaufbeuren (O(1)K) were used to immunize cattle (n=7). Animals were vaccinated once and 21 days after immunization animals were infected with the homologous virus. Four animals were protected. After vaccination, as well as after challenge infection, B- and T-cell responses were examined. Sera were tested for virus- and peptide-specific antibodies and showed after vaccination only a weak antibody response. After challenge infection, an increase in antibody titre was obvious but there was no correlation between antibody titre and protection. The reactivity of the cellular immune system was detected by analyses of PBMCs for virus- and peptide-specific T-lymphocytes. With regard to the virus-specific T-lymphocytes, a heterogeneous reactivity could be shown. No correlation between virus-specific T-cell proliferation and protection was found. Obvious was the fact that all protected animals showed after vaccination a strong T-cell response against at least one of the peptides used for immunization. These results suggest a correlation between the onset of an antigen-specific T-cell reaction and protection.
No takes yet. Share an insight, caveat, or question.
Höhlich et al. (2003) studied Foot-and-mouth disease (FMD) (n=7). Lipopeptide vaccination with FMDV-specific B-cell epitopes was evaluated on Protection against challenge infection with homologous virus. Lipopeptide vaccination with FMDV-specific B-cell epitopes protected 4 out of 7 cattle against challenge infection with homologous foot-and-mouth disease virus.
Synapse has enriched 10 related papers. Consider them for comparative context: